On May 5, 2023, Gilead Sciences Inc announced that at its annual meeting of shareholders held on May 3, 2023, a shareholder proposal requesting the Company to amend the company governing documents to give street name shares and non-street name shares an equal right to call a special stockholder meeting was not approved and Company board nominee Anthony Welters nomination was approved by shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.06 USD | +3.62% |
|
+0.56% | -19.69% |
14/06 | Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup | DJ |
14/06 | EU regulator mandates label updates on CAR-T cancer therapies | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.69% | 8.11TCr | |
+41.96% | 63TCr | |
-7.15% | 35TCr | |
+18.77% | 33TCr | |
+8.79% | 30TCr | |
+18.02% | 25TCr | |
+1.27% | 22TCr | |
+11.95% | 22TCr | |
+3.68% | 16TCr | |
-4.38% | 16TCr |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Declaration of Voting Results by Gilead Sciences Inc